Systemic administration of Shikonin ameliorates cognitive impairment and neuron damage in NPSLE mice

[1]  Huangli Xu,et al.  Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth , 2022, British journal of cancer.

[2]  Huangli Xu,et al.  Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth , 2022, British Journal of Cancer.

[3]  J. Saez-Rodriguez,et al.  Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions , 2021, Immunity.

[4]  Yayi Hou,et al.  Hippocampal microglia CD40 mediates NPSLE cognitive dysfunction in mice , 2021, Journal of Neuroimmunology.

[5]  Tim Bartels,et al.  Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases , 2020, Science.

[6]  Chunfang Liu,et al.  Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways. , 2020, Journal of ethnopharmacology.

[7]  A. Ergul,et al.  Microglia knockdown reduces inflammation and preserves cognition in diabetic animals after experimental stroke , 2020, Journal of Neuroinflammation.

[8]  A. Vo,et al.  Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus , 2020, Current opinion in neurology.

[9]  Jianhong Zhu,et al.  Shikonin ameliorates D-galactose-induced oxidative stress and cognitive impairment in mice via the MAPK and nuclear factor-κB signaling pathway. , 2020, International immunopharmacology.

[10]  A. Yang,et al.  Role of Interleukin-6 in Depressive Disorder , 2020, International journal of molecular sciences.

[11]  Yi-nan Chen,et al.  The Mast Cell Is an Early Activator of Lipopolysaccharide-Induced Neuroinflammation and Blood-Brain Barrier Dysfunction in the Hippocampus , 2020, Mediators of inflammation.

[12]  C. Putterman,et al.  Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus. , 2019, Current opinion in rheumatology.

[13]  Jieyu Liu,et al.  Identification of neurotoxicity markers induced by realgar exposure in the mouse cerebral cortex using lipidomics. , 2019, Journal of hazardous materials.

[14]  Yitao Wang,et al.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine , 2019, Chinese Medicine.

[15]  T. Kubota,et al.  Monoclonal anti‐dsDNA antibody 2C10 escorts DNA to intracellular DNA sensors in normal mononuclear cells and stimulates secretion of multiple cytokines implicated in lupus pathogenesis , 2019, Clinical and experimental immunology.

[16]  T. Yu,et al.  Knockout of TLR4 promotes fracture healing by activating Wnt/β-catenin signaling pathway. , 2019, Pathology, research and practice.

[17]  I. Campbell,et al.  Microglia responses to interleukin‐6 and type I interferons in neuroinflammatory disease , 2019, Glia.

[18]  Cheng Peng,et al.  Pharmacological Properties and Derivatives of Shikonin-A Review in Recent Years. , 2019, Pharmacological research.

[19]  S. Carrasco,et al.  CD4+CD69+ T cells and CD4+CD25+FoxP3+ Treg cells imbalance in peripheral blood, spleen and peritoneal lavage from pristane-induced systemic lupus erythematosus (SLE) mice , 2019, Advances in rheumatology.

[20]  Mei Zhang,et al.  Baicalein improves cognitive deficits and hippocampus impairments in temporal lobe epilepsy rats , 2019, Brain Research.

[21]  A. Jacques,et al.  Contextual Fear Conditioning Alter Microglia Number and Morphology in the Rat Dorsal Hippocampus , 2019, Front. Cell. Neurosci..

[22]  G. Vásquez,et al.  Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus. , 2019, Autoimmunity reviews.

[23]  Zhanjun Jia,et al.  Shikonin attenuates acetaminophen-induced acute liver injury via inhibition of oxidative stress and inflammation. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[24]  C. Putterman,et al.  Neuropsychiatric lupus: new mechanistic insights and future treatment directions , 2019, Nature Reviews Rheumatology.

[25]  Guo-yi Gao,et al.  Inhibition of ferroptosis attenuates tissue damage and improves long‐term outcomes after traumatic brain injury in mice , 2018, CNS neuroscience & therapeutics.

[26]  X. Gu,et al.  Circadian rhythm resynchronization improved isoflurane-induced cognitive dysfunction in aged mice , 2018, Experimental Neurology.

[27]  Xuedong Jia,et al.  Paeoniflorin attenuates depressive behaviors in systemic lupus erythematosus mice. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[28]  S. Wen,et al.  FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus , 2018, Brain, Behavior, and Immunity.

[29]  A. Cardona,et al.  The IL-1β phenomena in neuroinflammatory diseases , 2018, Journal of Neural Transmission.

[30]  Xuan Luo,et al.  Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice , 2018, Journal of neuroinflammation.

[31]  U. Panjwani,et al.  Inhibiting the microglia activation improves the spatial memory and adult neurogenesis in rat hippocampus during 48 h of sleep deprivation , 2017, Journal of Neuroinflammation.

[32]  B. Shukitt-Hale,et al.  Nutritional Factors Affecting Adult Neurogenesis and Cognitive Function. , 2017, Advances in nutrition.

[33]  L. Nadel,et al.  Viewpoints: how the hippocampus contributes to memory, navigation and cognition , 2017, Nature Neuroscience.

[34]  K. Hwang,et al.  HM71224, a selective Bruton’s tyrosine kinase inhibitor, attenuates the development of murine lupus , 2017, Arthritis Research & Therapy.

[35]  A. Rahman,et al.  A critical analysis of the tools to evaluate neuropsychiatric lupus , 2017, Lupus.

[36]  Tuan Leng Tay,et al.  Microglia across the lifespan: from origin to function in brain development, plasticity and cognition , 2017, The Journal of physiology.

[37]  Huaxi Xu,et al.  TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway , 2017, The Journal of Neuroscience.

[38]  M. Govoni,et al.  The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. , 2016, Journal of autoimmunity.

[39]  Shuntaro Sato,et al.  Predictors of clinical outcomes in patients with neuropsychiatric systemic lupus erythematosus. , 2016, Cytokine.

[40]  G. Kempermann,et al.  Resveratrol Enhances Neuroplastic Changes, Including Hippocampal Neurogenesis, and Memory in Balb/C Mice at Six Months of Age , 2015, PloS one.

[41]  M. Samson,et al.  Brain Invasion by Mouse Hepatitis Virus Depends on Impairment of Tight Junctions and Beta Interferon Production in Brain Microvascular Endothelial Cells , 2015, Journal of Virology.

[42]  Sheng Wang,et al.  Protective Effect of Shikonin in Experimental Ischemic Stroke: Attenuated TLR4, p-p38MAPK, NF-κB, TNF-α and MMP-9 Expression, Up-Regulated Claudin-5 Expression, Ameliorated BBB Permeability , 2013, Neurochemical Research.

[43]  A. Basu,et al.  Interleukin‐1β orchestrates underlying inflammatory responses in microglia via Krüppel‐like factor 4 , 2013, Journal of neurochemistry.

[44]  W. Brück,et al.  Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons , 2013, Acta Neuropathologica.

[45]  Joseph E LeDoux,et al.  Molecular Mechanisms of Fear Learning and Memory , 2011, Cell.

[46]  H. Kettenmann,et al.  Physiology of microglia. , 2011, Physiological reviews.

[47]  Jian-ning Zhang,et al.  The Wnt /β‐catenin signaling pathway in the adult neurogenesis , 2011, The European journal of neuroscience.

[48]  Hui-Chen Chen,et al.  Shikonin inhibits maturation of bone marrow‐derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma , 2010, British journal of pharmacology.

[49]  Bo Zhang,et al.  Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activity. , 2010, European journal of pharmacology.

[50]  J. Ioannidis,et al.  EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs , 2010, Annals of the rheumatic diseases.

[51]  U. Mrowietz,et al.  Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation , 2010, Journal of Neuroinflammation.

[52]  Y. Takasaki,et al.  FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice. , 2010, Biochemical and biophysical research communications.

[53]  B. Morasco,et al.  Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies , 2010, Neurobiology of Disease.

[54]  Yan Yan Wang,et al.  Effects of shikonin isolated from zicao on lupus nephritis in NZB/W F1 mice. , 2009, Biological & pharmaceutical bulletin.

[55]  Ji-Ho Park,et al.  Shikonins attenuate microglial inflammatory responses by inhibition of ERK, Akt, and NF-κB: neuroprotective implications , 2008, Neuropharmacology.

[56]  M. Mattson,et al.  Curcumin Stimulates Proliferation of Embryonic Neural Progenitor Cells and Neurogenesis in the Adult Hippocampus* , 2008, Journal of Biological Chemistry.

[57]  B. Volpe,et al.  Neuropsychiatric systemic lupus erythematosus reconsidered , 2008, Nature Clinical Practice Rheumatology.

[58]  S. Maier,et al.  Rapid isolation of highly enriched and quiescent microglia from adult rat hippocampus: Immunophenotypic and functional characteristics , 2006, Journal of Neuroscience Methods.

[59]  D. Kletsas,et al.  Evaluation of the anti-inflammatory and cytotoxic activities of naphthazarine derivatives from Onosma leptantha. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[60]  A. Okamoto,et al.  Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice , 2004, Clinical and experimental immunology.

[61]  Xin Chen,et al.  Cellular pharmacology studies of shikonin derivatives , 2002, Phytotherapy research : PTR.

[62]  C. Stevens,et al.  Aquaporin 4 and glymphatic flow have central roles in brain fluid homeostasis , 2021, Nature Reviews Neuroscience.

[63]  Carmagnola Al.  [The mast cell]. , 1988, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[64]  H. Davson.  Blood–brain barrier , 1977, Nature.

[65]  S. Hirohata.  Neuropsychiatric Systemic Lupus Erythematosus , 2018, Springer International Publishing.

[66]  L. Cui,et al.  Protective Effect of Shikonin in Experimental Ischemic Stroke: Attenuated TLR4, p-p38MAPK, NF-κB, TNF-α and MMP-9 Expression, Up-Regulated Claudin-5 Expression, Ameliorated BBB Permeability , 2013, Neurochemical Research.